Anti-aging pill startup Elysium Health inks at least $20 million in Series B funding

Comment

Image Credits:

Elysium Health markets a pill formulated with ingredients it says will keep you feeling young and, according to a source close to the matter and documents obtained by TechCrunch, the startup has closed on $20 million in Series B financing at what we’re told is a $157 million valuation led by General Catalyst and participation from an ARCH Venture Partners investor.

Reached for comment, Elysium suggested that our information is outdated, but declined to provide more information.

Update: ARCH Venture Partners says it is not a participant but investor Robert Nelson has confirmed he is an individual investor in Elysium’s latest funding round. General Catalyst confirmed it led the round.

However, the price is consistent with prior reporting in New York Magazine that the company was seeking $20 million in funding.

According to Elysium’s most recent (10/27/2016) Restated Articles of Incorporation the startup also raised $6.1 million in previously unreported Series A and $109,000 in Series A-1 funding rounds, bringing the total funding to approximately $26.2 million.

Elysium, which launched 18 months ago, has attracted some interest from those in the supplement industry for the scientific rigor and longevity claims applied to its first product called Basis. It is also co-founded by a former Sequoia Capital partner Eric Marcotulli, former J.P. Morgan exec Dan Alminana and head of aging research Leonard Guarente and includes a scientific advisory board with six Nobel Laureates.

A formidable team, to be sure. And it seems to be part of a growing trend of Silicon Valley companies hopping on the longevity bandwagon in the last few years. Google, now Alphabet, launched life extension research startup Calico, Larry Ellison has poured $400 million into the Lawrence Ellison Foundation to focus on aging and both J. Craig Venter and XPRIZE’s Peter Diamand teamed up to form genomics company Human Longevity, Inc.

But are Elysium’s pills really the fountain of youth? Elysium claims its Basis product can do anything from helping you sleep better to repair your DNA, all leading up to a longer, healthier life. But the ingredients in these pills — a combination of nicotinamide riboside (NR) and pterostilbene — are not proprietary. For one they occur naturally in blueberries and milk, and for another you can actually buy both ingredients used in Elysium’s pills in separate bottles on Amazon for around $19 for a 30-day supply of NR and $12 for a 60-day supply of pterostilbene.

Elysium sells its Basis product, the combination of these two ingredients, for $50 per month or $60 for a one-time purchase.

We asked Elysium about the non-proprietary nature of its products back in July. Elysium defended its product then, telling TechCrunch, “Many supplement companies are not transparent about who, exactly, is managing and supporting the company” and that “Many supplements do not contain the ingredients listed on the label.” It also mentioned its commitment to scientific rigor and pointed out Basis is the only product on the market combining the two supplements.

While it’s pretty easy to combine pills and see the ingredients as we’re only dealing with two supplements here, Elysium does have a valid point about the standards in the U.S. vitamin industry. The startup has the means to prove its supplements actually work in a field with a reputation for selling snake oil to cure all manner of disease.

There’s also something to be said for branding. People buy vitamins and supplements they believe are good for them and rely heavily on the trust in the brand, though most amount to a lot of sugar or ingredients easily obtained for less somewhere else. Take, for example, Khloe Kardashian’s gummy bear hair vitamins, which sell for $84 but are essentially corn syrup and some biotin.

But Elysium also has work to do in proving its supplements actually do what it tells customers it can do right now. So far we don’t know if they actually can prolong the life of humans, just mice. Still, Elysium tells customers its products will work on them.

However, the startup is currently conducting a randomized, double-blind, placebo-controlled human clinical trial with 120 people between the ages of 60 to 80 under the same ground rules as typically required by the FDA for pharmaceutical studies — something rare in the highly unregulated supplement industry.

While, the FDA doesn’t deem aging as a disease itself, it does regulate certain drugs dealing with diseases associated with aging such as alzheimers so Elysium doesn’t have to get its Basis product approved before selling. But that also means it must rely on its scientific board for credibility — possibly raising eyebrows in the scientific community for selling pills based on unsubstantiated claims.

On the flip of that is of course a startup willing to test its product at a higher standard in an industry that doesn’t have to. There’s something to be said of that.

More TechCrunch

Blue Origin has successfully completed its NS-25 mission, resuming crewed flights for the first time in nearly two years. The mission brought six tourist crew members to the edge of…

Blue Origin successfully launches its first crewed mission since 2022

Creative Artists Agency (CAA), one of the top entertainment and sports talent agencies, is hoping to be at the forefront of AI protection services for celebrities in Hollywood. With many…

Hollywood agency CAA aims to help stars manage their own AI likenesses

Expedia says Rathi Murthy and Sreenivas Rachamadugu, respectively its CTO and senior vice president of core services product & engineering, are no longer employed at the travel booking company. In…

Expedia says two execs dismissed after ‘violation of company policy’

Welcome back to TechCrunch’s Week in Review. This week had two major events from OpenAI and Google. OpenAI’s spring update event saw the reveal of its new model, GPT-4o, which…

OpenAI and Google lay out their competing AI visions

When Jeffrey Wang posted to X asking if anyone wanted to go in on an order of fancy-but-affordable office nap pods, he didn’t expect the post to go viral.

With AI startups booming, nap pods and Silicon Valley hustle culture are back

OpenAI’s Superalignment team, responsible for developing ways to govern and steer “superintelligent” AI systems, was promised 20% of the company’s compute resources, according to a person from that team. But…

OpenAI created a team to control ‘superintelligent’ AI — then let it wither, source says

A new crop of early-stage startups — along with some recent VC investments — illustrates a niche emerging in the autonomous vehicle technology sector. Unlike the companies bringing robotaxis to…

VCs and the military are fueling self-driving startups that don’t need roads

When the founders of Sagetap, Sahil Khanna and Kevin Hughes, started working at early-stage enterprise software startups, they were surprised to find that the companies they worked at were trying…

Deal Dive: Sagetap looks to bring enterprise software sales into the 21st century

Keeping up with an industry as fast-moving as AI is a tall order. So until an AI can do it for you, here’s a handy roundup of recent stories in the world…

This Week in AI: OpenAI moves away from safety

After Apple loosened its App Store guidelines to permit game emulators, the retro game emulator Delta — an app 10 years in the making — hit the top of the…

Adobe comes after indie game emulator Delta for copying its logo

Meta is once again taking on its competitors by developing a feature that borrows concepts from others — in this case, BeReal and Snapchat. The company is developing a feature…

Meta’s latest experiment borrows from BeReal’s and Snapchat’s core ideas

Welcome to Startups Weekly! We’ve been drowning in AI news this week, with Google’s I/O setting the pace. And Elon Musk rages against the machine.

Startups Weekly: It’s the dawning of the age of AI — plus,  Musk is raging against the machine

IndieBio’s Bay Area incubator is about to debut its 15th cohort of biotech startups. We took special note of a few, which were making some major, bordering on ludicrous, claims…

IndieBio’s SF incubator lineup is making some wild biotech promises

YouTube TV has announced that its multiview feature for watching four streams at once is now available on Android phones and tablets. The Android launch comes two months after YouTube…

YouTube TV’s ‘multiview’ feature is now available on Android phones and tablets

Featured Article

Two Santa Cruz students uncover security bug that could let millions do their laundry for free

CSC ServiceWorks provides laundry machines to thousands of residential homes and universities, but the company ignored requests to fix a security bug.

2 days ago
Two Santa Cruz students uncover security bug that could let millions do their laundry for free

TechCrunch Disrupt 2024 is just around the corner, and the buzz is palpable. But what if we told you there’s a chance for you to not just attend, but also…

Harness the TechCrunch Effect: Host a Side Event at Disrupt 2024

Decks are all about telling a compelling story and Goodcarbon does a good job on that front. But there’s important information missing too.

Pitch Deck Teardown: Goodcarbon’s $5.5M seed deck

Slack is making it difficult for its customers if they want the company to stop using its data for model training.

Slack under attack over sneaky AI training policy

A Texas-based company that provides health insurance and benefit plans disclosed a data breach affecting almost 2.5 million people, some of whom had their Social Security number stolen. WebTPA said…

Healthcare company WebTPA discloses breach affecting 2.5 million people

Featured Article

Microsoft dodges UK antitrust scrutiny over its Mistral AI stake

Microsoft won’t be facing antitrust scrutiny in the U.K. over its recent investment into French AI startup Mistral AI.

2 days ago
Microsoft dodges UK antitrust scrutiny over its Mistral AI stake

Ember has partnered with HSBC in the U.K. so that the bank’s business customers can access Ember’s services from their online accounts.

Embedded finance is still trendy as accounting automation startup Ember partners with HSBC UK

Kudos uses AI to figure out consumer spending habits so it can then provide more personalized financial advice, like maximizing rewards and utilizing credit effectively.

Kudos lands $10M for an AI smart wallet that picks the best credit card for purchases

The EU’s warning comes after Microsoft failed to respond to a legally binding request for information that focused on its generative AI tools.

EU warns Microsoft it could be fined billions over missing GenAI risk info

The prospects for troubled banking-as-a-service startup Synapse have gone from bad to worse this week after a United States Trustee filed an emergency motion on Wednesday.  The trustee is asking…

A US Trustee wants troubled fintech Synapse to be liquidated via Chapter 7 bankruptcy, cites ‘gross mismanagement’

U.K.-based Seraphim Space is spinning up its 13th accelerator program, with nine participating companies working on a range of tech from propulsion to in-space manufacturing and space situational awareness. The…

Seraphim’s latest space accelerator welcomes nine companies

OpenAI has reached a deal with Reddit to use the social news site’s data for training AI models. In a blog post on OpenAI’s press relations site, the company said…

OpenAI inks deal to train AI on Reddit data

X users will now be able to discover posts from new Communities that are trending directly from an Explore tab within the section.

X pushes more users to Communities

For Mark Zuckerberg’s 40th birthday, his wife got him a photoshoot. Zuckerberg gives the camera a sly smile as he sits amid a carefully crafted re-creation of his childhood bedroom.…

Mark Zuckerberg’s makeover: Midlife crisis or carefully crafted rebrand?

Strava announced a slew of features, including AI to weed out leaderboard cheats, a new ‘family’ subscription plan, dark mode and more.

Strava taps AI to weed out leaderboard cheats, unveils ‘family’ plan, dark mode and more

We all fall down sometimes. Astronauts are no exception. You need to be in peak physical condition for space travel, but bulky space suits and lower gravity levels can be…

Astronauts fall over. Robotic limbs can help them back up.